Ampersand Capital Partners Closes AMP-26 at $1.5 Billion Ampersand Capital Partners, a Boston-based middle-market private equity firm dedicated to growth-oriented investments in healthcare and life sciences, has announced the closing of its latest fund, Ampersand 2026 (“AMP-26”) Limited Partnership, with $1.5 billion in limited partner commitments. The closing was announced on May 28, 2026. AMP-26 […]
Author Archives: Editorial
"DealNews.ai is produced by the DealNews.ai editorial desk, which covers mergers and acquisitions, private equity and venture capital activity across Europe and the Benelux. Articles are based on company announcements and primary sources, reviewed by our editors, and corrected promptly when errors are found. Questions or corrections can be sent through our contact page."
